U.S. Markets open in 6 hrs 52 mins

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
36.55-0.43 (-1.16%)
At close: 4:00PM EDT
People also watch
SRPTCLDXCLVSALNYACHN
  • C
    CE
    CE
    Anyone notice the 2 highest volume days in over a month were today and last Friday. Buyers coming in on Friday in case of weekend announcement ?
  • f
    frank
    frank
    e ive raised my numbers on acad. im now at $70-$110
  • E
    Eric
    Eric
    My opinion for an ACAD buy out is that $60 per share is not enough. (I would be glad with $60) but, if Nuplazid continues to get approved for other illnesses, they buy out should be more like $100 per share. I could also see ACAD going it alone and not doing a buy out. Whether or not ACAD gets bought out, I can see Nuplazid becoming a new, primary treatment standard in multiple use cases and not a second, third, or addition too another medication.
  • M
    Mark
    Mark
    Who gets bought out first ACAD or OMER?
  • M
    Me
    Me
    These ups and downs create mystery.
  • j
    jeff
    jeff
    whoop whoop!
    $60/share
  • f
    felix
    felix
    CT order filed with SEC today....
  • f
    frank
    frank
    im betting 100% on buy out i got a dollar
  • M
    Mitchell
    Mitchell
    $ACAD management preparing for the #buyout by $PFE $AZN
    #CEO gets stock option for 243,750 shares exercisable at $35.80 (will vest on b/o)
  • f
    frank
    frank
    you sign a deal with rest of world we go to $60 a share , come on man!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
  • S
    Sweet
    Sweet
    Landmark M&A Deals Continue to Shape Big Pharma

    8:30 am ET September 6, 2017 (PR Newswire)

    (This is a small section from the above article)
    In both of these cases, high-dollar acquisitions were fueled by strong intellectual property positions targeting inviting markets within the pharmaceutical industry. This trend rings true when studying other upstart companies that could be in line for big time buyouts. A buyout of ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) has been rumored for months, with the company having reportedly received an offer from AstraZeneca in February and interest from Pfizer related to its lead product NUPLAZID(R), the only significant compound in the company's development pipeline. Approved by the FDA for the treatment of hallucinations and delusions associated with Parkinson's disease, NUPLAZID(R) is currently in late stage trials for similar symptoms in Alzheimer's and schizophrenia, giving it the potential to address a massive and growing global market. The company's stock closed at $36.16 on September 1, and reports from Seeking Alpha suggest that ACADIA's management team is pushing for a substantial premium for a potential buyout in the range of $55 to $60 a share.
  • K
    Kej
    Kej

    Things are looking good...

    https://www.standard.co.uk/business/market-report-astrazeneca-in-spotlight-as-traders-revive-chatter-over-bid-for-us-firm-acadia-a3630196.html

    Market report: AstraZeneca in spotlight as traders revive bid chatter
    Rumours resurfaced today that drugs giant AstraZeneca is preparing to go on the takeover trail. Speculation in the City suggested the FTSE 100 giant is preparing to swoop on Acadia Pharmaceuticals, a San Diego-based firm listed on Nasdaq with a marke
    www.standard.co.uk
  • C
    CE
    CE
    I have been long for many years but all these articles today from Margret Patrick from unknown Market Realist carry's zero weight. another pump and dump. Now on the potential AZ take over hopefully that has some legs.
  • D
    Don1
    Don1

    http://marketrealist.com/2017/09/nuplazid-expected-become-leading-central-nervous-system-drug-future-years/?utm_source=yahoo&utm_medium=feed&yptr=yahoo

    Nuplazid Expected to Become a Leading Central Nervous System Drug - Market Realist
    On April 29, 2016, the FDA approved Acadia Pharmaceuticals’ (ACAD) Nuplazid (pimavanserin) as a first therapy for treating patients with Parkinson’s disease (or PD) psychosis.
    marketrealist.com
  • m
    magoo
    magoo
    Sweet. Hurricane party my house. Windermere Florida. Path has it going right owner is 2am Sunday.
    Have to love Florida .. 2004 Charlie came right up I4 our primary highway I was outside and the winds really do hold you up. My first hurricane. We had 4 that year. I was ok I saw one no more please.
    Have to laugh. My 5 year old a little scared.
    Acad looking great!
  • A
    Astro
    Astro
    when phase 3 schizophrenia data out?
  • d
    d
    d
    1mm shares in the 1st hour. What's up ?
  • S
    Simon
    Simon
  • M
    Mary
    Mary
    what's going on over at ATRS, nice move. Near term catalyst may be sparking interest.